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Crohn’s disease and ulcerative colitis, known together as inﬂammatory bowel diseases
(IBDs), and celiac disease are the most common disorders affecting not only adults but also
children. Both IBDs and celiac disease are associated with oxidative stress, which may play
a  signiﬁcant role in their etiologies. Reactive oxygen species (ROS) such as superoxide radi-
cals  (O2• ), hydroxyl radicals (•OH), hydrogen peroxide (H2O2), and singlet oxygen (1O2) are
responsible for cell death via oxidation of DNA, proteins, lipids, and almost any other cellular
constituent. To protect biological systems from free radical toxicity, several cellular antioxi-
dant defense mechanisms exist to regulate the production of ROS, including enzymatic and
nonenzymatic pathways. Superoxide dismutase catalyzes the dismutation of O2• to H2O2
and oxygen. The glutathione redox cycle involves two enzymes: glutathione peroxidase,
which uses glutathione to reduce organic peroxides and H2O2; and glutathione reductase,
which reduces the oxidized form of glutathione with concomitant oxidation of nicotinamide
adenine dinucleotide phosphate. In addition to this cycle, GSH can react directly with free
radicals. Studies into the effects of free radicals and antioxidant status in patients with
IBDs  and celiac disease are scarce, especially in pediatric patients. It is therefore very neces-sary to conduct additional research studies to conﬁrm previous data about ROS status and
antioxidant activities in patients with IBDs and celiac disease, especially in children.
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.  Reactive  oxygen  species  and  the
ntioxidant  defense  system
eactive oxygen species (ROS), including superoxide radicals
O2• ), hydroxyl radicals (•OH), hydrogen peroxide (H2O2), and
inglet oxygen (1O2) are generated as by-products of nor-
al  metabolism in biological systems.1,2 Low levels of ROS
re essential for several physiological processes, including
rotein phosphorylation, transcription factor activation, cell
ifferentiation, apoptosis, cell immunity, and as secondary
essengers in the regulation of cardiac and vascular cell
unctioning.3 Excessive ROS may have detrimental effects on
arget cellular components such as DNA, proteins, and lipids.4
ccumulative evidence indicates that oxidative stress plays
 major role in the initiation and progression of a number
f human diseases such as cancer, hyperlipidemia, diabetes
ellitus, metabolic disorders, atherosclerosis, cardiovascular
iseases (hypertension, ischemic heart disease, chronic heart
ailure), and neurodegenerative diseases.5
Most cell types are capable of generating ROS under cer-
ain conditions. However, the major sources of these reactive
olecules are phagocytic cells, especially macrophages, Kupf-
er cells, polymorphonuclear neutrophils (PMNs), endothelial
ells, and various epithelial cell types, including enterocytes,
epatocytes, alveolar epithelial cells, and renal tubular epithe-
ial cells.6
Mitochondria are the main organelles responsible for the
roduction of ROS during physiological and pathological
tates. These organelles have their own ROS scavenging mech-
nisms required for cell survival.7 Despite this, it has been
hown that mitochondria generate ROS at an amount higher
han their scavenging capacity.8 O2• is initially formed via
 large number of pathways, including normal cellular respi-
ation, the metabolism of arachidonic acid by lipoxygenases
nd cyclo-oxygenases and from inﬂammatory and endothe-
ial cells.9 The main sources of O2• are respiratory complexes
 (NADH dehydrogenase) and III (ubisemiquinone) located at
he inner mitochondrial membrane, which generate a small
mount of O2• as a side product of electron transport during
xidative phosphorylation.10 O2• is released into the matrix
y complex I, whereas it is released into both the matrix and
he intermembranous space by complex III. Complex III forms
2
• during cycling of the electron acceptor ubiquinone, which
an donate electrons to molecular oxygen on both the internal
nd the external face of the mitochondrial inner membrane.11
A variety of enzymatic and nonenzymatic processes can
enerate ROS. Among the most important sources are the
eactions catalyzed by the enzymes nicotinamide adenine
inucleotide phosphate (NADPH) oxidase and xanthine oxi-
ase (XO).6 NADPH oxidase (NOX family of enzymes) is
n enzyme complex that is assembled after the activation
f phagocytes by microbes or microbial products, such as
ipopolysaccharide or various proinﬂammatory mediators. In
esting cells, the components of NADPH oxidase are present
n the cytosol and the membranes of various intracellular
rganelles. Upon cell activation, the components are assem-
led on a membrane-bound vesicle, which then fuses with
he plasma membrane, resulting in the release O2• outward
nto the extracellular milieu and inward into the phagocytic251
vesicle.12 The reaction catalyzed by NADPH oxidase is critical
for the formation of ROS in macrophages and PMNs. NADPH
oxidase, however, is also present in other cell types, including
vascular smooth muscle cells and endothelial cells.13 The liver
and the gut are rich sources of xanthine oxidoreductase (XOR),
which catalyzes the production of uric acid. XOR exists in
two interconvertible forms: XO and xanthine dehydrogenase
(XDH).14 Human XOR exists in vivo in the dehydrogenase form
but is easily converted to XO by oxidation of the sulfhydryl
residues or through proteolysis.15 Differences are evident
between the substrate afﬁnities for the XO and XDH subforms.
Additionally, XDH preferentially reduces NAD+, whereas XO
cannot reduce NAD+, preferring molecular oxygen. Reduction
of molecular oxygen by either form of the enzyme yields O2•
and H2O2.14,15 Under certain circumstances, nitric oxide syn-
thase (NOS) can generate O2• in addition to nitric oxide (NO).
If the concentration of l-arginine or BH4 is low, or if BH4 is
oxidized, NOS becomes uncoupled and generates signiﬁcant
amounts of O2• .16 This also occurs when NADPH oxidase acti-
vation leads to the oxidation of BH4.17 In a separate reaction,
myeloperoxidase (MPO), which is abundant in phagocytes, cat-
alyzes H2O2 to produce HOCl and other oxidizing species.18 It
also utilizes NO to generate ROS, thereby reducing NO bioac-
tivity and increasing oxidative stress.19
Peroxynitrite (ONO2−) is generated in a diffusion-controlled
reaction of O2• and NO, potentially causing oxidative damage
via the nitration of tissues.20 ONO2− is a key element in resolv-
ing the contrasting roles of NO in physiology and pathology.21
Under proinﬂammatory conditions, simultaneous produc-
tion of O2• and NO can be strongly activated to increase
production 1000-fold, which will increase the formation of
peroxinitrite by a factor of 1 million. Without O2• , the for-
mation of nitrogen dioxide by the reaction of NO with oxygen
is miniscule by comparison. There is no requirement for NO
and O2• to be produced within the same cell to form per-
oxinitrite, as NO can readily move through membranes and
between cells.9,21
The enzymatic–nonenzymatic antioxidant cellular defense
system plays a key role in protecting biological systems
from ROS by regulating the production of free radicals and
their metabolites.22 The primary antioxidant enzymes against
superoxide radicals include superoxide dismutase (SOD), cata-
lase (CAT), and glutathione peroxidase (GPx). These enzymes
act together in the metabolic pathway of ROS, and altered
activity of one enzyme without compensatory changes in oth-
ers may lead to lipid peroxidation.9,22,23
1.1.  Mechanism  of  O2• scavenging
SODs are enzymes based around a metal cofactor that func-
tions to catalytically convert O2• to oxygen (O2) and H2O2.24
These enzymes can be classiﬁed into four groups: iron SOD
(Fe-SOD) is found in the chloroplasts of eukaryotic cells; man-
ganese SOD (Mn-SOD) is typically found in mitochondria and
can also be found in peroxisomes; copper–zinc SOD (Cu/Zn-
SOD), which is usually the most abundant SOD located in the
chloroplast, in the cytosol, and in the extracellular space; and
nickel SOD (Ni-SOD), which has been isolated from a number
of Streptomyces bacteria and from cyanobacteria.25
252  
In eukaryotic cells, the intracellular level of O2• is reg-
ulated by the activities of the two fundamental scavenger
enzymes, namely, Cu/Zn-SOD and Mn-SOD. These enzymes
catalyze the dismutation of O2• to H2O2 and O2. The Cu/Zn-
SOD enzyme, located in cytosol, lysosomes, nucleus, and the
mitochondrial intermembranous space, contains two protein
subunits—each of which bears an active site containing one
Cu and one Zn cation.26 Copper is the redox-active metal,
changing between the 2+/3+ oxidation states during cataly-
sis, and zinc appears to play a role in overall enzyme stability
and in facilitating function independent of pH.27 The proposed
enzymatic mechanism for Cu/Zn-SOD follows two stages: the
ﬁrst is the reduction of the oxidized Cu(II) form of the enzyme
by superoxide, releasing dioxygen; and in the second, the
reduced Cu(I) is oxidized by another superoxide anion and
two protons, generating H2O2. Mn-SOD in eukaryotic cells
is expressed mainly in the mitochondria and contains man-
ganese at its active sites. The MnSOD dismutation mechanism
involves cycling between oxidized (Mn3+) and reduced (Mn2+)
ions.25
O2• + Cu(II)/Zn-SOD → Cu(I)/Zn-SOD
O2• + Cu(I)/Zn-SOD + 2H+ → H2O2 + Cu(II)/Zn-SOD
1.2.  Mechanism  of  H2O2 scavenging
The dismutation of O2• generates H2O2, which is usually
removed in cells by two types of enzymes, catalase and
peroxidases.3,28
GPx, an enzyme dependent on the micronutrient selenium,
plays a crucial role in the reduction of lipid and hydrogen
peroxides. If GPx activity is decreased, more  H2O2 is present,
leading to direct tissue damage.29 There are four subspecies
of GPx: GPx1 is ubiquitous and found in the cytosol of most
cells, including red blood cells; GPx2 is also cytosolic but is con-
ﬁned to the gastrointestinal tract; GPx3 occurs in the plasma
as a glycoprotein; and GPx4 is found in mitochondria, where
it interacts with complex lipids, such as cholesterol and lipo-
proteins damaged by free radicals.30
CAT is a heme-containing peroxisomal enzyme important
in the decomposition of intracellular H2O2.28 There are three
types of CAT: typical or monofunctional catalases such as
mammal-type catalases, bifunctional catalase-peroxidases,
and pseudo catalases. Mammalian catalases are active as
tetramers and show little peroxidase activity, and the tar-
get molecules are limited to small organic substrates. The
second group, catalase-peroxidases, are bifunctional, act-
ing both as catalase and peroxidase, and can use a variety
of organic substances as hydrogen donors. In contrast to
monofunctional catalases, catalase-peroxidases are active as
dimers or tetramers. Pseudo catalases, also called non-heme
manganese-containing catalases, are non-heme catalases
containing only three characterized and sequenced enzymes
from different bacterial species. Activity is derived from a
manganese-rich reaction center rather than a heme group.31,32
Catalases from many  species are known to be tetramers
of subunits, each of which contains a ferric heme group
(Fe-protoheme IX moiety) bound to its active sites.28 EachIntegr Med Res ( 2 0 1 6 ) 250–258
tetrameric molecule of mammalian catalases contains four
molecules of tightly bound NADPH, which does not appear
to be essential for the enzymic conversion of H2O2 to H2O
and O2, but protects catalase against inactivation by H2O2.33
The enzyme can function in two ways: catalytically, decompo-
sing H2O2 into water and oxygen ( phase); or peroxidatively,
by eliminating H2O2 by oxidizing alcohols, formate, or nitrate
( phase).34 In eukaryotes, catalase is localized in the peroxi-
somes. The catalytic mechanism is a two-step reaction: in the
ﬁrst, the heme Fe3+ reduces H2O2 to H2O and generates a cova-
lent Fe4+= O species with a porphorin -cation radical, referred
to as compound I; in the second, compound I oxidizes a sec-
ond peroxide molecule to O2 and releases the ferryl oxygen
species as H2O. The catalase reaction is basically a dismuta-
tion reaction similar to SOD, without the production of free
radicals.35
Catalase-Fe3+ + H2O2 → Compound I + H2O
H2O2 + Compound I → Catalase-Fe3+ + H2O + O2
GPx consists of four protein subunits, each of which con-
tains one atom of selenium, comprising the integral structural
component of the enzyme active site.30,36 This selenopro-
tein catalyzes the reduction of H2O2 using glutathione (GSH)
as the reducing substrate.22 In short, the enzyme catalytic
site includes a selenocysteine residue in which the selenium
undergoes a redox cycle involving selenol (E-SeH) as the active
form that reduces hydrogen peroxides and organic peroxi-
des. The selenol is oxidized to selenenic acid (E-SeOH), which
reacts with reduced GSH to form a selenenyl sulﬁde adduct
(E-Se-SG). A second GSH then regenerates the active form of
the enzyme by attacking E-Se-SG to form oxidized glutathione
(GSSG). Thus, in the overall process, two equivalents of GSH are
oxidized to disulﬁde and water, whereas the hydroperoxide is
reduced to the corresponding alcohol.22,37
E-SeH + H2O2 → E-SeOH + H2O
E-SeOH + GSH → E-Se-SG + H2O
E-Se-SG + GSH → E-SeH + GSSG
The enzymatic activity of both CAT and GPx operates simul-
taneously in most cells. H2O2 synthesized by peroxisomal
enzymes is mostly eliminated by CAT, whereas H2O2 arising
from mitochondria or by the action of cytosolic Cu/Zn-SOD is
eliminated by GPx.22,30
1.3.  Mechanism  of •OH  scavenging
•OH is a very short-lived and highly reactive free radical
formed by the successive monovalent reduction of O2 in
cell metabolism. It can potentially react with all biological
molecules such as DNA, proteins, lipids, and almost any con-
stituent of cells.38 Owing to the absence of any enzymatic
mechanism for the elimination of this highly reactive ROS,
excess production of •OH ultimately leads to cell death.39 It
is generally assumed that •OH is synthesized in biological
systems in the presence of H2O2 and iron ions, known as
PH
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aber–Weiss reaction. The ﬁrst step involves the reduction of
erric into ferrous ion:
e3+ + O2• → Fe2+ + O2
The second step is the Fenton reaction:
e2+ + H2O2 → Fe3+ + •OH + OH
Recent studies have demonstrated that •OH is formed not
nly in vivo under hypoxic conditions, but can be generated
n vitro under reducing conditions in the presence of ascorbic
cid and iron ions.40,41 An even more  novel mechanism is a
evelation of the generation of •OH catalyzed by ferric ions
ithout any additional redox agent, which can be considered
 special case of the Fenton reaction42:
e3+ + OH− → Fe2+ + •OH
It appears from this that the Fenton reaction is a conve-
ient generator of •OH with known implications in health
nd disease.43 There are many  existing studies describing the
ffect of natural protein extracts and newly  synthesized mark-
rs as •OH scavengers. Nordihydroguaiaretic acid (NDGA), a
lant phenolic lignan, scavenges •OH efﬁciently.44 In addition,
he reaction of NDGA and •OH is predicted to be diffusion-
ontrolled. The ﬁrst step of this reaction is proposed to occur
ainly by a sequential electron proton transfer from NDGA
o •OH, generating a neutral radical of NDGA. After a second
xidation step, this gives a diradical that produces a cyclic
ompound after a cascade sequential complex reaction.45 The
lectrochemical studies performed in water support the for-
ation of a cyclic compound (C2) as the main product of the
eaction. It is concluded that NDGA can scavenge at least two
OH. Moreover, aminoantipyrines, pyrazolone derivates, were
emonstrated to be highly efﬁcient scavengers of •OH owing
he mechanism of hydroxylation of the aromatic ring.45,46
.4.  Mechanism  of  ONO2− scavenging
nhibition of peroxynitrite-mediated oxidation reactions by
xcess NO or O2• occurs via scavenging •OH and nitrogen
ioxide (•NO2), which are formed from the decomposition
f ONO2−.47 Upon protonation from ONO2− to peroxynitrous
cid (ONOOH, pKa = 6.5–6.8), the peroxynitrite anion rapidly
ecomposes at physiological pH to form nitrate (NO3−), free
OH, and nitrogen dioxide •NO2. Recent studies indicate that
he yield of •OH and •NO2 formation reaches approximately
5–35% in the absence of competitive reactions.48 NADH reacts
ith •OH and •NO2 formed during the self-decomposition
f ONO2−, whereas GSH directly reacts with peroxynitrite at
 neutral pH.49 Thus, NADH may only competitively inhibit
hose reactions that involve •OH and •NO2 and not peroxyni-
rite itself.47
A number of groups have investigated the reaction of uric
50cid with peroxynitrite. Kuzkaya et al have reported that
he scavenging of peroxynitrite by uric acid is important in
reventing the oxidation of BH4, which would lead to NOS
ncoupling.253
1.5.  GSH  redox  cycle
Glutathione reductase (GR) is an equally important antioxi-
dant enzyme, which plays a critical role in GSH metabolism,
reducing glutathione disulﬁde (GSSG) to the sulfhydryl form,
GSH, by the NADPH-dependent mechanism. The function of
the enzyme is to keep the cellular concentration of reduced
GSH high and that of its oxidized form, GSSG, low.51,52
Regarding the nonenzymatic antioxidant defense system,
GSH is mentioned in this review. GSH, the most abundant
nonprotein thiol, is composed of the amino acids glutamine,
cysteine, and glycine.53 This tripeptide can exist intracellu-
larly in either an oxidized (GSSG) or reduced (GSH) state.53 Its
function is regulation via several mechanisms: GSH nonen-
zymaticaly reacts with O2• and •OH; is an essential cofactor
for a number of enzymes (e.g., as an electron donor for the
reduction of H2O2 or other peroxides catalyzed by GPx); mod-
ulates a variety of protein functions via S-glutathionylation;
and has an important role to serve as a carrier/storage form for
cysteine.22,52,54 Maintaining optimal GSH/GSSG ratios in the
cell is critical to survival—that is, GSH is signiﬁcantly advanta-
geous over GSSG under healthy physiological conditions.55,56
GR is a thermostable homodimeric ﬂavoprotein in which
each subunit contains four domains. The dimeric nature of
the enzyme is critical for its function, because both sub-
units contribute essential residues to the constitution of
the active site. It is noteworthy that different GR isoforms
are found not only in the cytosol, but also in the mito-
chondrial matrix and chloroplasts.22,57 Functionally, GR is
an NADPH:GSSG oxidoreductase.58 The enzyme essentially
has three substrates, namely NADPH, H+, and GSSG and two
products, namely, GSH and GSH.59 The catalytic cycle of GR
has two phases: a reductive and oxidative half-reaction. Dur-
ing the reductive half-reaction, ﬂavin adenine dinucleotide,
a prosthetic group of GR, is reduced by NADPH and reducing
equivalents are transferred to a redox active disulﬁde. In the
oxidative half-reaction, the resulting dithiol reacts with the
GSSG, which is reduced to form two GSH at the active site of
GR.58
GSSG + NADPH + H+ → 2GSH + NADP+
2.  Evidence  of  ROS  in  human  diseases
Currently published scientiﬁc studies have demonstrated that
ROSs are involved in more  than 60 health concerns.60 In
rheumatoid arthritis, hydroxyl radicals cause degradations of
proteoglycans and H2O2 easily inhibits cartilage proteoglycan
synthesis by interfering with ATP synthesis. Peroxynitrite and
hypochlorous acid may facilitate cartilage damage by inac-
tivating tissue inhibitors of metalloproteinases and reacting
with ascorbate. The resulting low levels of ascorbate in syno-
vial ﬂuid can be harmful as it is essential for normal cartilage
function.61,62 In carcinogenesis, high reactive hydroxyl radi-
cals cause oxidative DNA damage and peroxynitrite, which
causes both oxidative damage and nitration of DNA bases.63
The majority of mutations induced by ROS appear to involve
guanine modiﬁcation, causing guanine (G) → thymin (T)
transversions. If it relates to critical genes such as oncogenes
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or tumor suppressor genes, initiation or progression of cancer
can result.64 Various studies on diabetes, one of the most com-
mon  chronic diseases worldwide, have shown an increased
formation of free radicals and decrease in antioxidant poten-
tial. Free radicals, especially O2• , are formed excessively by
glucose oxidation, nonenzymatic glycation of proteins, and
the subsequent oxidative degradation of glycated proteins.
Sustained hyperglycemia may cause decreased radical scav-
enging by Mn-SOD and the GSH redox cycle.65,66
ROSs are particularly active in neuronal tissue as the
excitatory amino acids and neurotransmitters; nevertheless,
they are involved in many  neurodegenerative processes.67 In
Alzheimer’s diseases, amyloid- peptide and advanced glyca-
tion end products are potential sources of ROS. The toxicity of
amyloid- peptide is attributed to histidine residues. Binding
of Cu2+ and Fe3+ produces toxic chemical reaction, altering the
oxidation state of both metals, producing H2O2 catalytically
in the presence of transition metals, ﬁnally producing toxic
•OH.68 Parkinson’s disease is characterized by mutations of -
synuclein protein in substantia nigra. Evidence indicates that
mutations in -synuclein protein have a role in modulating the
dopamine activity, which is responsible for ROS production.69
Dopamine is a very good metal chelator and electron donor
with a high tendency to coordinate with Cu2+ and Fe3+. This
binding leads to the reduction of the metals initiating Fenton’s
chemistry to generate H2O2.70 Another identiﬁed mechanism
of ROS synthesis is also examined in multiple sclerosis.71
Xanthine oxidase catalyzes the oxidation of hypoxanthine to
xanthine, thereby generating large quantities of ROS, includ-
ing O2• and its dismutation product, H2O2.72
The inﬂuence of oxidative stress was demonstrated in the
pathogenesis of gastrointestinal diseases.73 It has been shown
that the concentration of ROS is increased in patients with
liver diseases such as alcoholic hepatitis and cirrhosis.74 Colon
cancer, as well as acute and chronic pancreatitis, have also
been associated with oxidative stress.75,76 It has been sug-
gested that oxidative stress may have an important role in
the pathogenesis of acquired megacolon. Necrotizing entero-
colitis, a severe disorder found in infants, is another disease
whose pathogenesis is attributed to oxidative stress as well as
Helicobacter pylori infection, an important factor in the patho-
genesis of gastric cancer. It is also followed by an increased
production of ROS.77
3.  ROS  and  antioxidants  in  intestinal
diseases
3.1.  Free  radicals  in  inﬂammatory  bowel  diseases
Inﬂammatory bowel diseases (IBDs), which include Crohn’s
disease (CrD) and ulcerative colitis (UC), are caused by a
chronic and uncontrolled inﬂammation of the intestinal
mucosa, which can affect any part of the gastrointestinal
tract.78,79 IBDs are most commonly diagnosed in adolescents,
young adults, and also in children.80 The inﬂammation in UC is
limited to the mucosa and submucosa of the colon. It begins
in the rectum prior to spreading proximally in a continuous
fashion and frequently involves the periappendiceal region.81
By contrast, CrD affects any part of the gastrointestinal tract,Integr Med Res ( 2 0 1 6 ) 250–258
most commonly the terminal ileum or the perianal region.82
The precise etiology of IBDs is still not fully clariﬁed, so the
number of patients has been increasing worldwide, especially
in North America and Western Europe. Various effects such
as environmental factors, disease susceptibility genes, and
dysregulated immune reactions including ROS may play a con-
siderable role in the pathogenesis of IBDs.83,84
In the gastrointestinal tract, sources of ROS involve xan-
thine oxidase, amine oxidase, and aldehyde oxidase as well
as the NADPH oxidase found in the macrophages of mucosal
lamina propria. The mediator of toxicity seems to be •OH.85
However, it cannot be considered as the only strong oxidizing
agent in the gut. Classically activated macrophages produce
proinﬂammatory cytokines and NO through inducible NOS
(iNOS).86 iNOS is a high-output source of NO as it is readily
induced by proinﬂammatory cytokines and is unresponsive
to changes in intracellular calcium.87 NO may mediate both
antioxidant and pro-oxidant effects. The activation of guany-
late cyclase to produce cGMP should also be mentioned in
addition to other beneﬁcial effects: its activation of cGMP-
dependent kinases and modulation of calcium levels in the
cells mediates and modulates many  physiological functions
and stress responses. Nitrosative stress acts in prevention of
apoptosis by S-nitrosylation of caspases.88
In chronic inﬂammation or relapsing immune activation
within the gastrointestinal tract, the pro-oxidant phase begins
to dominate, thus defeating the enteric smooth muscles,
enteric nerves, and cells in close special contact, intersti-
tial cells of Cajal (ICC), manifesting typical IBD symptoms.
This suggests some previously established facts. In animal
models of IBD, as well as CrD and UC, increased numbers
of mast cells have been found.89–91 Functional activity of
mast cells is mostly associated with degranulation and the
release of heparin, histamine, serotonin, and proteases.92
Because the activity of proteases is in many  ways beneﬁcial
to the inactivation of toxins or proinﬂammatory cytokines
and inﬂuences activation of matrix metalloproteinase cas-
cades even in nonmast cells, it also shows conﬂicting effects.93
In the inﬂamed mucosa of the intestine, there are a large
number of polymorphonuclear leukocytes (PMNLs), mono-
cytes, and lymphocytes.94 Activation of PMNLs and monocytes
may induce enhanced formation of HOCl, which is more
toxic than either O2• or H2O2 and nonspeciﬁcally reacts
with sulfhydryls, polyunsaturated fatty acids, DNA, pyri-
dine, nucleotides, and aromatic amino acids.95 Intestinal
macrophages isolated from CrD patients were shown to be
more  responsive to stimulation for O2• production than
peripheral blood monocytes following increased NADPH-
oxidase expression.96 The neutrophils from patients with UC
were able to generate increased levels of O2• when compared
with those of control individuals. Thus, increased O2• synthe-
sis can be attributed to monocytes invading into the mucosa
and increased vascular endothelium permeability.97
It is important to note that in both predominant stimu-
lations of iNOS activity, the formation of peroxynitrite is an
inevitable process. It causes damage to enzymes and other
structures more  easily, either by strong oxidizing particu-
lates in radical reactions, inactivation of iron sulfur centers,
inactivation by nitration, or by degranulating proteases. It is
not surprising that recent studies showed that the mucosa
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f patients with active CrD or UC had decreased levels
f SOD.83 Recently, many  studies have focused on direct
ctivation of transient receptor potential (TRP) channels by
2
• , H2O2, NO, downstream products of lipid peroxidation
uch as 4-hydroxynonenal, 4-oxononenal, 9-nitrooleate, dehy-
rated prostanoids, and by cysteine-modifying agents in a
oncentration-dependent manner.98–100 Since the task of the
hannels is to provide homeostasis of calcium and magne-
ium ions, pacemaker activity of the ICCs, and smooth muscle
unction, it is not surprising that the stress-induced activ-
ty of some channels (in particular TRPA1, TRPV1, TRPV4,
RPM4-8) is in the background of the pathophysiological signs
f gastrointestinal diseases.100 For example, it was shown
hat degranulation of mast cells evoked just by psychologi-
al stress activates an “alarm program” in the enteric nervous
ystem to produce symptoms such as diarrhea and abdomi-
al distress.101 It is well documented that GPx, with respect
o its isoforms, is transcriptionally upregulated by oxidative
echanisms and as a part of oxidative stress response.102
nderstandably, in a study on UC patients either in active
r remission stage, a signiﬁcant increase in GPx activity was
ound in inﬂamed mucosa. Further studies also conﬁrmed sig-
iﬁcantly higher plasma GPx levels in patients in the UC and
rD groups than those in the control group; this did not change
ased on whether the disease was in the active or remission
hase.103
However, the effects of oxidative stress on neurons differ. In
n animal model of colitis, the changes in motility were proven
o be due to selective loss of neuronal NOS immunoreactive
eurons in myenteric plexus.104 Representing the opposite sit-
ation to that previously stated, via excessive production of
O by iNOS, De Giorgio et al105 demonstrated that neuronal
oss was mediated through a caspase-3-dependent pathway.
owever, the loss of neurons was also associated with the
ppearance of eosinophilic and neutrophilic inﬁltrates into
yenteric ganglia.106 Neuronal injury is also associated with
emarkable loss of ICCs in myenteric plexus, which coordinate
euronal activity with gastrointestinal motility and smooth
uscle function.91 Both immunologically activated mast cells
nd macrophages are found close to ICCs, providing cytopro-
ection for ICCs through the heme oxidase-1 (HO-1) pathway
r mediating further dysfunction through fusion or transgran-
lation of granules.91,107,108 HO-1 is upregulated mainly in
acrophages and has two main effects. First, it increases the
xpression of c-kit (tyrosine kinase acting as a receptor for
tem cell factor) and neuronal NOS, and second, it mediates
arbon monoxide cytoprotection.107,109
.2.  Antioxidant  defense  in  celiac  disease
eliac disease (CD) is an immune-mediated chronic inﬂam-
atory disorder of the upper small intestine induced by
luten and related prolamines in genetically susceptible
ndividuals.91 As in other autoimmune conditions, environ-
ental, genetic, and immunological factors may be involved
n the pathogenesis of CD. In addition to this, oxidative
tress is also implicated in the pathogenesis of CD.110 The
esults of various explorations showed that gliadin disturbs
he pro-oxidant/antioxidant balance of affected individuals
hrough overproduction of ROS. Several in vitro studies have255
also reported redox imbalance and increased levels of free
radicals after the exposure of cells to gliadin. Earlier stud-
ies have noted that the activity of SOD markedly increases,
whereas the activity of GPx decreases signiﬁcantly.111 Sele-
nium deﬁciency has already been reported in celiac patients
with regard to low GPx activity.112 Stojiljkovic´  et al showed that
the antioxidant capacity of celiac patients is weakened by  a
depletion of GSH and reduced activities of the GSH-dependent
antioxidant enzymes GPx and GR.112 Conversely, the activity
of CAT did not vary signiﬁcantly in celiac patients with respect
to the control group. CAT is most efﬁcient against high H2O2
concentrations, and more  effective protection is given by GPx
when the H2O2 levels are lower.111,113
3.3.  Antioxidant  status  in  intestinal  diseases  of
children
IBDs and celiac diseases are the most common disorders diag-
nosed not only in adults but also in children, a currently
expanding group affected by these diseases.114 Nevertheless,
data concerning ROS status and antioxidant defense in chil-
dren patients with UC, CrD, and CD are scarce.115 The study
of Stojiljkovic´ et al. showed increased SOD activity, whereas
GPx and GR activities and GSH content were signiﬁcantly
reduced in children with celiac disease.116 CAT activity in
celiac patients did not change in comparison to the control
group. In this case, the antioxidant capacity of young celiac
patients is signiﬁcantly reduced, mostly through depletion of
GSH. Activation of xanthine oxidase is one of the mechanisms
of ROS overproduction in small intestinal mucosa of celiac
patients.111 The results of Boda et al117 showed activation of
xanthine oxidase in enterocytes in children with CD, which
results in overproduction of ROS and further damage to the
mucosa. Children with IBDs had increased GPx activity and
GSH content compared with control children. These differ-
ences were found primarily in children with CrD.111,118,119
Children are a very vulnerable group for research, and for
this reason there is an important role for ethic codexes for
research and consent of parents. Owing to the lack of relevant
research data, it is necessary to carry out additional studies to
build on the amount of previously conducted studies.
4.  Conclusion
The role of oxidative stress in pathological changes in the gas-
trointestinal tract has mostly been studied in adults. It has
been suggested that ROS plays an important role in the initi-
ation as well as the progression of IBDs and celiac disease. In
the pediatric age group, several epidemiological studies have
been published with evidence suggesting that the incidence of
IBD has increased recently. A similar trend is also observed in
children with celiac disease. It is therefore necessary to con-
tinue research on these diseases to improve the quality of life
of these patients, especially children.Conﬂicts  of  interest
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